Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas
Christine H. Chung(Moffitt Cancer Center), Fred R. Hirsch(Tisch Hospital), Loris McGavran(Children's Hospital Colorado), Robert J. Sinard(Vanderbilt University Medical Center), Brian B. Burkey(University of Colorado Cancer Center), Marileila Varella‐Garcia(University of Colorado Anschutz Medical Campus), James L. Netterville(Breast Cancer Research Foundation), Shawn Levy(HudsonAlpha Institute for Biotechnology), Carolyn Jarrett(University of Colorado Cancer Center), Anthony J. Cmelak(Breast Cancer Research Foundation), Barbara A. Murphy(Vanderbilt University Medical Center), Joel S. Parker(University of North Carolina at Chapel Hill), Jesse Carter(University of Colorado Cancer Center), Kim Ely(Bipar), Wendell G. Yarbrough(University of North Carolina at Chapel Hill), Natalie B. Parker(University of Colorado Cancer Center), Robbert J.C. Slebos(University of Iowa)
Cited by 572
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Next-generation genotype imputation service and methods
|Nature Genetics|2016|4.5k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k